Vardenafil

This classification denotes a cgmp phosphodiesterase inhibitor with the molecular formula C23H32N6O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UCE6F4125H, chemically known as 2-(2-ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3h-imidazo(5,1-f)(1,2,4)triazin-4-one but generally known as vardenafil, which bears US NIH Compound Identifier 110634. European Medicines Agency schedules Vardenafil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20047. The term VARDENAFIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). World Health Organization schedules vardenafil in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule vardenafil under HS 29350090 and SITC 51580. As of Q4 2014, VARDENAFIL remains the US FDA Preferred Term for this commodity. Vardenafil bears US NLM identifiers UMLS ID C0971579 and NCI Concept Code C66650. SMILES: S(=O)(=O)(N1CCN(CC1)CC)C1CC(C(OCC)CC1)C1[NH]N2C(NC(C2C(=O)N1)C)CCC.